V Neuschmelting1, C Weiss Lucas2, G Stoffels3, A-M Oros-Peusquens3, H Lockau4, N J Shah5, K-J Langen6, R Goldbrunner2, C Grefkes7. 1. From the Departments of Neurosurgery (V.N., C.W.L., R.G.) Department of Radiology (V.N., H.L.), Memorial Sloan Kettering Cancer Center, New York, New York volker.neuschmelting@uk-koeln.de. 2. From the Departments of Neurosurgery (V.N., C.W.L., R.G.). 3. Institute for Neuroscience and Medicine (G.S., A.-M.O.-P., N.J.S., K.-J.L., C.G.), Forschungszentrum Jülich, (Institute for Neuroscience and Medicine [INM]-2, INM-3, INM-4), Juelich, Germany. 4. Radiology (H.L.) Department of Radiology (V.N., H.L.), Memorial Sloan Kettering Cancer Center, New York, New York. 5. Institute for Neuroscience and Medicine (G.S., A.-M.O.-P., N.J.S., K.-J.L., C.G.), Forschungszentrum Jülich, (Institute for Neuroscience and Medicine [INM]-2, INM-3, INM-4), Juelich, Germany Departments of Neurology (N.J.S.). 6. Institute for Neuroscience and Medicine (G.S., A.-M.O.-P., N.J.S., K.-J.L., C.G.), Forschungszentrum Jülich, (Institute for Neuroscience and Medicine [INM]-2, INM-3, INM-4), Juelich, Germany Nuclear Medicine (K.-J.L.), Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany. 7. Neurology (C.G.), University of Cologne, Cologne, Germany Institute for Neuroscience and Medicine (G.S., A.-M.O.-P., N.J.S., K.-J.L., C.G.), Forschungszentrum Jülich, (Institute for Neuroscience and Medicine [INM]-2, INM-3, INM-4), Juelich, Germany.
Abstract
BACKGROUND AND PURPOSE: Motor deficits in patients with brain tumors are caused mainly by irreversible infiltration of the motor network or by indirect mass effects; these deficits are potentially reversible on tumor removal. Here we used a novel multimodal imaging approach consisting of structural, functional, and metabolic neuroimaging to better distinguish these underlying causes in a preoperative setting and determine the predictive value of this approach. MATERIALS AND METHODS: Thirty patients with malignant brain tumors involving the central region underwent a hybrid O-(2-[(18)F]fluoroethyl)-L-tyrosine-PET-MR imaging and motor mapping by neuronavigated transcranial magnetic stimulation. The functional maps served as localizers for DTI tractography of the corticospinal tract. The spatial relationship between functional tissue (motor cortex and corticospinal tract) and lesion volumes as depicted by structural and metabolic imaging was analyzed. RESULTS: Motor impairment was found in nearly all patients in whom the contrast-enhanced T1WI or PET lesion overlapped functional tissue. All patients who functionally deteriorated after the operation showed such overlap on presurgical maps, while the absence of overlap predicted a favorable motor outcome. PET was superior to contrast-enhanced T1WI for revealing a motor deficit before the operation. However, the best correlation with clinical impairment was found for T2WI lesion overlap with functional tissue maps, but the prognostic value for motor recovery was not significant. CONCLUSIONS: Overlapping contrast-enhanced T1WI or PET-positive signals with motor functional tissue were highly indicative of motor impairment and predictive for surgery-associated functional outcome. Such a multimodal diagnostic approach may contribute to the risk evaluation of operation-associated motor deficits in patients with brain tumors.
BACKGROUND AND PURPOSE:Motor deficits in patients with brain tumors are caused mainly by irreversible infiltration of the motor network or by indirect mass effects; these deficits are potentially reversible on tumor removal. Here we used a novel multimodal imaging approach consisting of structural, functional, and metabolic neuroimaging to better distinguish these underlying causes in a preoperative setting and determine the predictive value of this approach. MATERIALS AND METHODS: Thirty patients with malignant brain tumors involving the central region underwent a hybrid O-(2-[(18)F]fluoroethyl)-L-tyrosine-PET-MR imaging and motor mapping by neuronavigated transcranial magnetic stimulation. The functional maps served as localizers for DTI tractography of the corticospinal tract. The spatial relationship between functional tissue (motor cortex and corticospinal tract) and lesion volumes as depicted by structural and metabolic imaging was analyzed. RESULTS:Motor impairment was found in nearly all patients in whom the contrast-enhanced T1WI or PET lesion overlapped functional tissue. All patients who functionally deteriorated after the operation showed such overlap on presurgical maps, while the absence of overlap predicted a favorable motor outcome. PET was superior to contrast-enhanced T1WI for revealing a motor deficit before the operation. However, the best correlation with clinical impairment was found for T2WI lesion overlap with functional tissue maps, but the prognostic value for motor recovery was not significant. CONCLUSIONS: Overlapping contrast-enhanced T1WI or PET-positive signals with motor functional tissue were highly indicative of motor impairment and predictive for surgery-associated functional outcome. Such a multimodal diagnostic approach may contribute to the risk evaluation of operation-associated motor deficits in patients with brain tumors.
Authors: Andreas Stadlbauer; Thilo Hammen; Peter Grummich; Michael Buchfelder; Torsten Kuwert; Arnd Dörfler; Christopher Nimsky; Oliver Ganslandt Journal: J Nucl Med Date: 2011-08 Impact factor: 10.057
Authors: Barbara Bobek-Billewicz; Gabriela Stasik-Pres; Krzysztof Majchrzak; Waldemar Senczenko; Henryk Majchrzak; Marek Jurkowski; Jakub Połetek Journal: Folia Neuropathol Date: 2011 Impact factor: 2.038
Authors: Marion Rapp; Alexander Heinzel; Norbert Galldiks; Gabriele Stoffels; Jörg Felsberg; Christian Ewelt; Michael Sabel; Hans J Steiger; Guido Reifenberger; Thomas Beez; Heinz H Coenen; Frank W Floeth; Karl-Josef Langen Journal: J Nucl Med Date: 2012-12-11 Impact factor: 10.057
Authors: Matthew J McGirt; Debraj Mukherjee; Kaisorn L Chaichana; Khoi D Than; Jon D Weingart; Alfredo Quinones-Hinojosa Journal: Neurosurgery Date: 2009-09 Impact factor: 4.654
Authors: Thomas Obermueller; Michael Schaeffner; Julia Gerhardt; Bernhard Meyer; Florian Ringel; Sandro M Krieg Journal: BMC Cancer Date: 2014-01-14 Impact factor: 4.430
Authors: Zhaolin Chen; Sharna D Jamadar; Shenpeng Li; Francesco Sforazzini; Jakub Baran; Nicholas Ferris; Nadim Jon Shah; Gary F Egan Journal: Hum Brain Mapp Date: 2018-08-04 Impact factor: 5.038
Authors: Martin Kocher; Christiane Jockwitz; Philipp Lohmann; Gabriele Stoffels; Christian Filss; Felix M Mottaghy; Maximilian I Ruge; Carolin Weiss Lucas; Roland Goldbrunner; Nadim J Shah; Gereon R Fink; Norbert Galldiks; Karl-Josef Langen; Svenja Caspers Journal: Cancers (Basel) Date: 2021-05-14 Impact factor: 6.639
Authors: James R Larkin; Manon A Simard; Axel de Bernardi; Vanessa A Johanssen; Francisco Perez-Balderas; Nicola R Sibson Journal: Int J Radiat Oncol Biol Phys Date: 2020-01-17 Impact factor: 7.038